Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?

被引:1
|
作者
Galazka, Jakub Krzysztof [1 ]
Czeczelewski, Marcin [2 ]
Kucharczyk, Tomasz [3 ]
Szklener, Katarzyna [4 ]
Mandziuk, Slawomir [4 ]
机构
[1] Med Univ Lublin, Chair Clin Oncol & Chemotherapy, Students Sci Assoc, 8 Jaczewskiego St, PL-20954 Lublin, Poland
[2] Med Univ Lublin, Dept & Clin Intervent Radiol & Neuroradiol, Students Sci Assoc, Lublin, Poland
[3] Med Univ Lublin, Lab Immunol & Genet, Lublin, Poland
[4] Med Univ Lublin, Chair Clin Oncol & Chemotherapy, Lublin, Poland
关键词
programmed death ligand-1; lung cancer; obesity; oncology; pulmonology; obesitology; BODY-MASS INDEX; VITAMIN-D; MORTALITY; RISK;
D O I
10.5114/aoms/175470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: In this retrospective study, the authors evaluated whether obesity -induced immunomodulation impacts the expression of programmed death ligand-1 (PD -1L) in lung cancer cells. Methods: A retrospective cross-sectional study was performed. The study included 67 patients. The data did not have a normal distribution. Results: For women, using ANOVA test (p = 0.050) with post -hoc analysis, a statistically significant difference in expression was found between women with overweight and women with normal weight (p = 0.040). Conclusions: Apart from the above, the authors did not find any statistically significant correlation between PD -1L expression on lung cancer cells and body mass index, either in the whole group or in histological subgroups.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [1] Programmed death ligand-1 (PD L-1) expression in cervical cancer patients
    L, A. S.
    Lakshmi, S.
    Preethi, T. R.
    Mathew, A.
    Kumar, A.
    Joseph, J.
    Mathews, S.
    James, F. V.
    ANNALS OF ONCOLOGY, 2020, 31 : S643 - S643
  • [2] Characterizing Programmed Death Ligand 1 (PD-1L) Expression in Merkel Cell Carcinoma
    Hanna, G. J.
    Grote, H. J.
    Vergara, V.
    Brunkhorst, B.
    Rabinowits, G.
    Thakuria, M.
    LeBoeuf, N. R.
    Cuillerot, J. M.
    DeCaprio, J. A.
    Lorch, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 951 - 952
  • [3] Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer
    Pereira, Marina A.
    Ramos, Marcus Fernando Kodama P.
    Ribeiro e Ribeiro, Renan
    Dias, Andre R.
    Ribeiro, Ulysses, Jr.
    Zilberstein, Bruno
    Cecconello, Ivan
    Mello, Evandro Sobroza
    Castria, Tiago B.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E208 - E208
  • [4] Programmed Death Ligand-1 (PD-L1) Expression and Prognostic Value in Synovial Sarcoma
    Kozak, K.
    Rembiszewska, A.
    Podgorska, A.
    Kosela-Paterczyk, H.
    Przybyl, J.
    Gos, A.
    Switaj, T.
    Wagrodzki, M.
    Prochorec-Sobieszek, M.
    Rutkowski, P.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S148 - S148
  • [5] PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION AND PROGNOSTIC VALUE IN SYNOVIAL SARCOMA
    Kozak, K.
    Szumera-Cieckiewicz, A.
    Rembiszewska, A.
    Podgorska, A.
    Paterczyk, H. M. Kosela
    Przybyl, J.
    Gos, A.
    Switaj, T.
    Prochorec-Sobieszek, M.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma
    Wang, Jennifer
    Rodriguez, Jaime
    Rao, Priya
    Pettaway, Curtis Alvin
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [7] Correlation of programmed Death Ligand-1 (PD-L1) expression with clinicopathological features in lung carcinoma in a Macedonian population
    Ognenoska-Jankovska, B.
    Basheska, N.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S335 - S335
  • [8] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    慢性疾病与转化医学(英文), 2019, 5 (03) : 170 - 177
  • [9] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Minuti, G.
    Gallo, M.
    De Luca, A.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
  • [10] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28